| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Human infection with a novel avian-origin influenza A (H7N9) virus.
|
N Engl J Med
|
2013
|
24.88
|
|
2
|
Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157.
|
Nucleic Acids Res
|
2002
|
4.92
|
|
3
|
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
|
Lancet
|
2013
|
3.83
|
|
4
|
Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery.
|
Nucleic Acids Res
|
2005
|
3.56
|
|
5
|
Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.
|
J Virol
|
2004
|
3.39
|
|
6
|
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity.
|
Nat Immunol
|
2013
|
2.64
|
|
7
|
Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment.
|
J Virol
|
2011
|
1.41
|
|
8
|
HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.
|
Mol Immunol
|
2009
|
1.31
|
|
9
|
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
|
J Gen Virol
|
2010
|
1.29
|
|
10
|
Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine.
|
Clin Infect Dis
|
2011
|
1.18
|
|
11
|
Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.
|
Clin Immunol
|
2008
|
1.14
|
|
12
|
Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.
|
Hepatology
|
2013
|
1.08
|
|
13
|
Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR.
|
J Biol Chem
|
2010
|
1.07
|
|
14
|
Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs.
|
J Virol
|
2010
|
1.04
|
|
15
|
Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication.
|
J Virol
|
2011
|
1.03
|
|
16
|
Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.
|
J Gen Virol
|
2007
|
1.03
|
|
17
|
Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33.
|
J Gen Virol
|
2011
|
0.99
|
|
18
|
Novel Norovirus GII.4 Variant, Shanghai, China, 2012.
|
Emerg Infect Dis
|
2013
|
0.99
|
|
19
|
HBsAg inhibits IFN-α production in plasmacytoid dendritic cells through TNF-α and IL-10 induction in monocytes.
|
PLoS One
|
2012
|
0.99
|
|
20
|
Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator.
|
PLoS Pathog
|
2011
|
0.98
|
|
21
|
Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells.
|
FEBS Lett
|
2006
|
0.98
|
|
22
|
Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
|
J Immunol
|
2013
|
0.97
|
|
23
|
Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component.
|
Biochem Biophys Res Commun
|
2006
|
0.96
|
|
24
|
Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis.
|
J Cell Biochem
|
2010
|
0.94
|
|
25
|
Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients.
|
Antivir Ther
|
2012
|
0.93
|
|
26
|
Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.
|
Proteomics
|
2006
|
0.91
|
|
27
|
Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model.
|
Antiviral Res
|
2013
|
0.91
|
|
28
|
Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus.
|
Emerg Infect Dis
|
2013
|
0.91
|
|
29
|
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation.
|
J Gen Virol
|
2009
|
0.90
|
|
30
|
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.
|
Antivir Ther
|
2013
|
0.90
|
|
31
|
The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis.
|
J Biol Chem
|
2003
|
0.89
|
|
32
|
CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination.
|
Immunology
|
2005
|
0.88
|
|
33
|
Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice.
|
Biochem Biophys Res Commun
|
2005
|
0.88
|
|
34
|
Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virus.
|
PLoS One
|
2011
|
0.87
|
|
35
|
Full-Genome Analysis of Influenza A(H7N9) Virus from Shanghai, China, 2014.
|
Genome Announc
|
2014
|
0.86
|
|
36
|
The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation.
|
Respir Physiol Neurobiol
|
2009
|
0.86
|
|
37
|
A novel norovirus GII.17 lineage contributed to adult gastroenteritis in Shanghai, China, during the winter of 2014–2015.
|
Emerg Microbes Infect
|
2015
|
0.85
|
|
38
|
Flavivirus replication complex assembly revealed by DNAJC14 functional mapping.
|
J Virol
|
2012
|
0.85
|
|
39
|
Co-infection with Avian (H7N9) and Pandemic (H1N1) 2009 Influenza Viruses, China.
|
Emerg Infect Dis
|
2015
|
0.85
|
|
40
|
In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.
|
J Clin Invest
|
2016
|
0.85
|
|
41
|
Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.
|
J Virol
|
2011
|
0.83
|
|
42
|
Rotavirus infection and its genetic characterization in non-hospitalized adults with acute gastroenteritis in Shanghai, China.
|
Arch Virol
|
2013
|
0.83
|
|
43
|
Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin.
|
Immunology
|
2003
|
0.83
|
|
44
|
Direct interaction between alpha-actinin and hepatitis C virus NS5B.
|
FEBS Lett
|
2003
|
0.82
|
|
45
|
Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease.
|
Acta Biochim Biophys Sin (Shanghai)
|
2010
|
0.82
|
|
46
|
Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).
|
J Biol Chem
|
2011
|
0.82
|
|
47
|
PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.
|
Emerg Infect Dis
|
2014
|
0.82
|
|
48
|
Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
|
Vaccine
|
2009
|
0.81
|
|
49
|
tRNA-dependent cleavage of the ColE1 plasmid-encoded RNA I.
|
Microbiology
|
2006
|
0.81
|
|
50
|
Processing of plasmid DNA with ColE1-like replication origin.
|
Plasmid
|
2004
|
0.81
|
|
51
|
Interferon-inducible MyD88 protein inhibits hepatitis B virus replication.
|
Virology
|
2004
|
0.81
|
|
52
|
Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus.
|
Acta Biochim Biophys Sin (Shanghai)
|
2010
|
0.80
|
|
53
|
Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
|
Virol Sin
|
2014
|
0.80
|
|
54
|
The 3' CCACCA sequence of tRNAAla(UGC) is the motif that is important in inducing Th1-like immune response, and this motif can be recognized by Toll-like receptor 3.
|
Clin Vaccine Immunol
|
2006
|
0.79
|
|
55
|
Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.
|
AIDS
|
2012
|
0.78
|
|
56
|
Cellular cIAP2 gene expression associated with anti-HBV activity of TNF-alpha in hepatoblastoma cells.
|
J Interferon Cytokine Res
|
2005
|
0.77
|
|
57
|
[Association between NS5A gene sequence and response to interferon therapy in chronic hepatitis C patients in Shanghai].
|
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
|
2002
|
0.77
|
|
58
|
A random PCR screening system for the identification of type 1 human herpes simplex virus.
|
J Virol Methods
|
2009
|
0.77
|
|
59
|
Gene delivery into hepatocytes with the preS/liposome/DNA system.
|
Biotechnol J
|
2008
|
0.77
|
|
60
|
Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.
|
Biochem Biophys Res Commun
|
2008
|
0.77
|
|
61
|
Proteomic analysis of cell lines expressing small hepatitis B surface antigen revealed decreased glucose-regulated protein 78 kDa expression in association with higher susceptibility to apoptosis.
|
J Med Virol
|
2010
|
0.76
|
|
62
|
A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients.
|
Medicine (Baltimore)
|
2016
|
0.76
|
|
63
|
Clinical and genetic characterization of measles viruses isolated from adult patients in Shanghai in 2006.
|
J Clin Virol
|
2007
|
0.75
|
|
64
|
[Modulation of allergic airway inflammation by immunostimulatory DNA sequences in conjunction with an allergen in a murine model of asthma].
|
Zhonghua Jie He He Hu Xi Za Zhi
|
2002
|
0.75
|
|
65
|
Classification of plasmid vectors using replication origin, selection marker and promoter as criteria.
|
Plasmid
|
2008
|
0.75
|